SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-076172
Filing Date
2020-06-23
Accepted
2020-06-23 21:00:19
Documents
1
Period of Report
2020-06-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2023254d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2023254d1_3.xml 3 6061
  Complete submission text file 0001104659-20-076172.txt   7800
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
Swartzburg Michael (Reporting) CIK: 0001659026 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36860 | Film No.: 20983611